Position in NKTR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,584,340
+$1,746,617 QoQ
Shares Held
165,941
+21.4% QoQ
Ownership
0.486%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 240 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 95%
None 5%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. NKTR ranks #57 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in NKTR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,584,340 | 165,941 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,837,723 | 136,730 | Shares | Defined | 2026-05-15 | |
| 2025-03-31 | $210,410 | 309,428 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $347,771 | 373,948 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $366,082 | 281,602 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $361,984 | 291,924 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $205,153 | 220,596 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $253,165 | 452,082 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $293,040 | 488,400 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $284,431 | 490,400 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $696,059 | 994,370 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $2,018,064 | 892,949 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,540,860 | 794,019 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,906,699 | 764,921 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,209,104 | 780,910 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,803,919 | 799,698 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,940,813 | 275,101 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,958,810 | 288,975 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $39,324,760 | 1,966,238 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,247,220 | 308,660 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,426,588 | 327,100 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $8,042,726 | 347,268 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $6,311,098 | 353,563 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||